ERBB2 and breast cancer: With regard to HER2 in breast cancer, many research teams have made great efforts to compare the expression difference between tumor tissue and CTCs, aiming to correlate the real-time HER2 status of CTCs with patient’s response to anti-HER2 therapy [14, 21].